MMJ Biopharma Cultivation Email Formats

About MMJ Biopharma Cultivation

MMJ BioPharma Cultivation, is the premier US medical cannabis cultivation and research company. MMJ BioPharma Cultivation’s mission is rooted in unlocking the potential of cannabinoid medicines to address serious medical conditions with limited treatment options. Unlike companies dealing with medical marijuana in states where it is federally illegal, MMJ BioPharma Cultivation has applied for a Drug Enforement Administration Schedule-I Bulk Manufacturer registration to cultivate plants for Food and Drug Administration approved medicines. MMJ BioPharma Cultivation will facilitate a process of scientific drug development and discovery governed by FDA protocol development processes, intellectual property portfolio and DEA regulatory manufacturing guidelines. MMJ is a biopharmaceutical company with a pioneering cannabis formulation (a prescribed pharmaceutical) of CBD (Cannabidiol)+THC (Tetrahydrocannabinol) via purified botanical extract. MMJ will be producing a targeted, personalized dose, of non-addictive, FDA-approved motor cortex and pain management drug as an alternative to the opiates. Once approved by the DEA, MMJ BioPharma Cultivation will be one of the first harvesters of cannabis plants to conduct a unique pharmaceutical research and development program into the medicinal uses of cannabis. Sowing will commence as soon as permitted, and the initial crop of 5,000 plants will be grown in a climate-controlled building at a secure research facility.

View contact profiles from MMJ Biopharma Cultivation